Raymond James analyst Rahul Sarugaser downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Outperform to Market Perform and announces $2.5 price target.
Raymond James Downgrades Ginkgo Bioworks Holdings to Market Perform, Announces $2.5 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.